SecBot SecBot
COURT-RULING ·Filed Oct 20, 2026

AMGN

AMGEN INC
NEUTRAL
Impact 1/10
Horizonimmediate Processed3d 5h ago CourtCourt Ruling · govinfo.gov
Court ruling (district)
Actionable Insight • Neutral

This is a routine procedural ruling with no material effect on Amgen's business or financials. No further action warranted.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+1d
AMGN ▲ +2.04% at T+1d
NEUTRAL call +2.04% · α vs SPY +3.22% · entry $438.34 → $447.28
Next anchor: T+5d tomorrow
Latest observation: T+2 -0.30% FF3 residual α
Entry = T+0 close
Oct 21, 2026
via day close
T+1d
+2.04%
call +2.04% · α +3.22%
$447.28
settled 5d ago
T+5d
Pending
tomorrow
T+20d
Pending
in 22d
T+60d
Pending
in 3mo

Price Chart

Loading chart...

Executive Summary

The court denied a pro se plaintiff's petition to vacate an arbitration award and granted Amgen's petition to confirm the award, upholding the arbitrator's denial of all employment discrimination claims against Amgen. This is a routine procedural win for Amgen with no financial exposure and no impact on operations or stock price.

Court Ruling Details

Ruling Date
Oct 20, 2026
Court
United States District Court for the Northern District of Texas, Dallas Division
Court Level
District
Judge
Sidney A. Fitzwater
Case Type
employment
Ruling Type
final judgment
Outcome
WIN — ruling favors this company
Precedent Risk
LOW

Key Facts

  • Plaintiff Marla Booker-Luton failed to timely serve notice of her petition to vacate the arbitration award within the FAA's 3-month deadline (June 30, 2026), making her petition untimely.
  • The arbitrator had already denied all of Booker-Luton's discrimination claims on March 30, 2026.
  • The court confirmed the arbitration award in favor of Amgen, ending the litigation.
  • No damages, penalties, or injunctive relief were awarded against Amgen.

Financial Impact

No financial impact — the ruling confirms Amgen's win in arbitration with zero damages awarded.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
43% bullish (42 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 court opinion.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-273058add5-AMGN
18 reports for AMGN
Performance horizon
86% Hit rate @ T+1 6 of 7 directional calls Went positive at some point 6 of 7 best @ T+60▲ +25.11%Jun 3, 2026
Filters
Rows
Reports for AMGN — sortable, filterable
TypeNow
Oct 20, 2026
7d ago
Court Ruling
NEUTRAL ★ 1/10
$438.34 $447.28▲ +2.04%▲ +3.22%$444.63 (+1.43%)
Oct 9, 2026
18d ago
Court Ruling
BEARISH ★ 6/10
$417.57 $412.84▲ +1.13%▲ +1.12%$444.63 (−6.48%)
Sep 10, 2026
6w ago
ANALYST-DOWNGRADE
BEARISH ★ 4/10
$382.47 $377.35▲ +1.34%▲ +2.19%$444.63 (−16.25%)
Sep 8, 2026
6w ago
ANALYST-DOWNGRADE
BEARISH ★ 4/10
$393.17 $391.27▲ +0.48%▲ +0.02%$444.63 (−13.09%)
Aug 14, 2026
10w ago
Court Ruling
BULLISH ★ 7/10
$419.38 $425.28▲ +1.41%▲ +2.08%$444.63 (+6.02%)
Aug 13, 2026
10w ago
Insider Cluster
NEUTRAL ★ 2/10
$415.21 $419.38▲ +1.00%▲ +1.48%$444.63 (+7.09%)
Aug 11, 2026
11w ago
Court Ruling
NEUTRAL ★ 3/10
$416.18 $417.84▲ +0.40%▼ −0.30%$444.63 (+6.84%)
Aug 7, 2026
11w ago
Insider Cluster
NEUTRAL ★ 2/10
$417.20 $414.30▼ −0.70%▼ −0.38%$444.63 (+6.57%)
Aug 7, 2026
11w ago
Insider Cluster
NEUTRAL ★ 2/10
$417.20 $414.30▼ −0.70%▼ −0.38%$444.63 (+6.57%)
Aug 7, 2026
11w ago
Insider Cluster
NEUTRAL ★ 2/10
$417.20 $414.30▼ −0.70%▼ −0.38%$444.63 (+6.57%)
Showing 10 of 18

US Market Status

Market Closed — Opens in 8h 14m

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
⚖ Court Ruling · govinfo.gov Report published Oct 23, 2026